1,146
Views
0
CrossRef citations to date
0
Altmetric
Bioengineering & Biotechnology

Network pharmacology- and molecular docking-based approach for predicting key targets and the potential mechanism of Tripterygium wilfordii Hook F for the treatment of acute lymphoblastic leukaemia

ORCID Icon, , & ORCID Icon
Pages 1160-1174 | Received 25 Jul 2021, Accepted 28 Sep 2022, Published online: 21 Nov 2022

References

  • Chen JH, Zheng WW, Jiang XD, Lu XY, Xu RZ. 2015. Triptolide induces apoptosis of human acute T lymphocyte leukemia Jurkat cells by inhibiting the transcription of retrovirus HERV-K Np9 gene. Journal of Southern Medical University. 35(05):702–706.
  • Craig RW. 1995. The BCL-2gene family. Semin Cancer Biology. 6(1):35–43.
  • Cui J, Wang Q, Wang J, Lv M, Zhu N, Li Y, Feng J, Shen B, Zhang J. 2009. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells. Molecular Cancer Therapeutics. 8(12):3214–22.
  • Diaz-Aguirre V, Velez-Pardo C, Jimenez-Del-Rio M. 2016. Fructose sensitizes Jurkat cells oxidative stress-induced apoptosis via caspase-dependent and caspase-independent mechanisms. Cell Biology International. 40(11):1162–1173.
  • DiNardo CD, Gharibyan V, Yang H, Wei Y, Pierce S, Kantarjian HM, Garcia-Manero G, Rytting M. 2013. Impact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia. American Journal of Hematology. 88(9):784–9.
  • Du X, Tong J, Lu H, He C, Du S, Jia P, Zhao W, Xu H, Li J, Shen Z, et al. 2017. Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemia. Molecular Medicine Reports. 16(1):101–108.
  • Fu HY, Shen JZ. 2005. The effect of triptolide on p15 gene expression in Molt4 cell line of acute lymphoblastic leukemia. Chinese Journal of Internal Medicine. 04:301–302.
  • Ganbarjeddi S, Azimi A, Zadi Heydarabad M, Hemmatzadeh M, Mohammadi S, Mousavi Ardehaie R, Zamani M, Baharaghdam S, Esmaeili S, Ghasemi A. 2020. Apoptosis induced by prednisolone occurs without altering the promoter methylation of BAX and BCL-2 genes in acute lymphoblastic leukemia cells CCRF-CEM. Asian Pacific Journal of Cancer Prevention. 21(2):523–529.
  • Gézsi A, Lautner-Csorba O, Erdélyi DJ, Hullám G, Antal P, Semsei ÁF, Kutszegi N, Hegyi M, Csordás K, Kovács G, et al. 2015. In interaction with gender a common CYP3A4 polymorphism may influence the survival rate of chemotherapy for childhood acute lymphoblastic leukemia. The Pharmacogenomics Journal. 15(3):241–7.
  • Gu L, Findley HW, Zhou M. 2002. MDM2 induces NF-κB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia. Blood. 99(9):3367–75.
  • Hao JX, Gao ZS, Gao H, Bi S, Wang J, Li ZJ. 2019. Discussion on the mechanism of Tripterygium wilfordii nephrotoxicity based on network pharmacology.Chinese. Journal of Experimental Formulas. 25(16):142–151.
  • Hassanzadeh A, Naimi A, Hagh MF, Saraei R, Marofi F, Solali S. 2019. Kaempferol improves TRAIL-mediated apoptosis in leukemia MOLT-4 cells by the inhibition of anti-apoptotic proteins and promotion of death receptors expression. Anti-Cancer Agents in Medicinal Chemistry. 19(15):1835–1845.
  • Hayden MS, Ghosh S. 2012. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes & Development. 26(3):203–234.
  • Huang M, Zhang HL, Liu T, Tian D, Gu LB, Zhou MX. 2013. Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway. Molecular Cancer Therapeutics. 12(2):184–194.
  • Hunger SP, Mullighan CG. 2015. Acute lymphoblastic leukemia in children. New England Journal of Medicine. 373(16):1541–52.
  • Hunger SP, Raetz EA. 2020. How I treat relapsed acute lymphoblastic leukemia in the pediatric population. Blood. 136(16):1803–1812.
  • Imran M, Salehi B, Sharifi-Rad J, Aslam Gondal T, Saeed F, Imran A, Shahbaz M, Tsouh Fokou PV, Umair Arshad M, Khan H, et al. 2019. Kaempferol: a key emphasis to its anticancer potential. Molecules. 24(12):2277.
  • Jammal N, Chew S, Jabbour E, Kantarjian H. 2020. Antibody based therapy in relapsed acute lymphoblastic leukemia. Best Practice & Research Clinical Haematology. 33(4):101225.
  • Kadioglu O, Nass J, Saeed ME, Schuler B, Efferth T. 2015. Kaempferol is an anti-inflammatory compound with activity towards NF-κB pathway proteins. Anticancer Res. 35(5):2645–2650.
  • Koomagi R, Zintl F, Sauerbrey A, Volm M. 2001. Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction. Clin Cancer Res. 7(11):3381–4.
  • Laane E, Panaretakis T, Pokrovskaja K, Buentke E, Corcoran M, Söderhäll S, Heyman M, Mazur J, Zhivotovsky B, Porwit A, et al. 2007. Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members. Haematologica. 92(11):1460–9.
  • Li L, Wang Y. 2020. Recent updates for antibody therapy for acute lymphoblastic leukemia. Experimental Hematology & Oncology. 9(1):33.
  • Liu L, Li G, Li Q, Jin Z, Zhang L, Zhou J, Hu X, Zhou T, Chen J, Gao N. 2013. Triptolide induces apoptosis in human leukemia cells through caspase-3-mediated ROCK1 activation and MLC phosphorylation. Cell Death & Disease. 4(12):e941–e941.
  • Luo D, Zuo ZY, Zhao HY, Tan Y, Xiao C. 2019. Immunoregulatory effects of Tripterygium wilfordii Hook F and its extracts in clinical practice. Front MED. 13(5):556–563.
  • Ma YN. 2016. The effect of triptolide on the epigenetics of acute T lymphocytic leukemia. Huazhong University of Science and Technology.
  • Malard F, Mohty M. 2020. Acute lymphoblastic leukaemia. The Lancet. 395(10230):1146–1162.
  • Manikandan P, Nagini S. 2018. Cytochrome P450 structure, function and clinical significance: a review. Current Drug Targets. 19(1):38–54.
  • Mata JF, Silveira VS, Mateo EC, Cortez MA, Queiroz RG, Yunes JA, Lee ML, Toledo SR, Petrilli AS, Brandalise SR, et al. 2010. Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL). Pediatric Blood & Cancer. 55(1):100–107.
  • Münch V, Trentin L, Herzig J, Demir S, Seyfried F, Kraus JM, Kestler HA, Köhler R, Barth TFE, Te Kronnie G, et al. 2017. Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor. Blood. 130(5):643–654.
  • Peirs S, Matthijssens F, Goossens S, Van de Walle I, Ruggero K, de Bock CE, Degryse S, Canté-Barrett K, Briot D, Clappier E, et al. 2014. ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia. Blood. 124(25):3738–47.
  • Ruefli-Brasse A, Reed JC. 2017. Therapeutics targeting Bcl-2 in hematological malignancies. Biochemical Journal. 474(21):3643–3657.
  • Shao LI, Zhang B. 2013. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chinese Journal of Natural Medicines 11(2):110–20.
  • Shi P, Zha J, Feng J, Jiang ZW, Zhao HJ, Deng MM, Liao NY, Li P, Jiang YR, Song HH, et al. 2021. Low-dose triptolide enhanced activity of idarubicin against acute myeloid leukemia stem-like cells via inhibiting DNA damage repair response. Stem Cell Reviews and Reports. 17(2):616–627.
  • Soung YH, Lee JW, Kim SY, Park WS, Nam SW, Lee JY, Yoo NJ, Lee SH. 2004. Somatic mutations of CASP3 gene in human cancers. Human Genetics. 115(2):112–5.
  • Sun LH. 2010. Screening of Chinese medicines for anti-acute lymphoblastic leukemia and study on the mechanism of action ingredients. Peking Union Medical College.
  • Tao H, Hu Q, Fang J, Liu A, Liu S, Zhang L, Hu Y. 2007. Expression of SODD and P65 in ALL of children and its relationship with chemotherapeutic drugs. Journal of Huazhong University of Science and Technology. 27(3):326–9.
  • Wang X, Wang ZY, Zheng JH, Li S. 2008. A systematic review of acupuncture and moxibustion treatment for chronic fatigue syndrome in china. The American Journal of Chinese Medicine. 36(1):1–24.
  • Wang X, Zhou M, Fu Y, Sun T, Chen J, Qin X, Yu Y, Jia J, Chen C. 2016. RBP2 promotes adult acute lymphoblastic leukemia by upregulating BCL2. PLoS One. 11(3):e0152142.
  • Wellmann S, Guschmann M, Griethe W, Eckert C, von Stackelberg A, Lottaz C, Moderegger E, Einsiedel HG, Eckardt KU, Henze G, Seeger K. 2004. Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF. Leukemia. 18(5):926–933.
  • Xu W, Wang X, Tu Y, Masaki H, Tanaka S, Onda K, Sugiyama K, Yamada H, Hirano T. 2019. Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells. Chemico-Biological Interactions. 310:108726.
  • Yang W, He X, He C, Peng L, Xing S, Li D, Wang L, Jin T, Yuan D. 2021. Impact of ESR1 polymorphisms on risk of breast cancer in the Chinese Han population. Clinical Breast Cancer. 21(3):e235–e242.
  • Zhang JL, Li H, Wang WJ, Huang SJ, Mang Y, Ding Y, Wen AD. 2021. Investigation on the mechanism of Salviae Miltiorrhizae-Cortex Moutan against cerebral ischemic injury based on network pharmacology. Nat Prod Res Dev. 33:103–113.
  • Zhang MX, Yang JW, Zhao XL, Zhao Y, Zhu S. 2021. Network pharmacology and molecular docking study on the active ingredients of qidengmingmu capsule for the treatment of diabetic retinopathy. Scientific Reports. 1(11):7382.
  • Zhang Y, Pillai G, Gatter K, Blázquez C, Turley H, Pezzella F, Watt SM. 2005. Expression and cellular localization of vascular endothelial growth factor A and its receptors in acute and chronic leukemias: an immunohistochemical study. Human Pathology. 36(7):797–805.
  • Zhang ZM, Yang L, Wang Y, Jiang S, Shang X, Qin DW, Duan JA. 2021. The synergic renoprotective effect of Rehmanniae Radix Preparata and Corni Fructus on adenine-induced chronic kidney disease rats based on integrated plasma metabolomics and network pharmacology approach. Life Sciences. 278:119545.
  • Zhao HJ. 2017. Low-concentration triptolide reverses the drug resistance of acute lymphoblastic leukemia by interfering with DNA damage repair. Southern Medical University.
  • Zhao X, Liu Z, Ren ZY, Wang HG, Wang ZS, Zhai JL, Cao D, Lyu SC, Li LX, Lang R, et al. 2020. Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharmacology of Tripterygium wilfordii Hook F. European Journal of Pharmacology. 880:173225.
  • Zou ZQ, Yue LJ, Ren YF. 2015. Association between CYP1A1* 2A polymorphism and susceptibility to childhood acute lymphoblastic leukemia: a meta analysis. Zhongguo Dang Dai Er Ke Za Zhi. 17(10):1112–8.